Genomics plc announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches
10 Oct 2022
Genomics plc have today announced a partnership with Our Future Health to generate polygenic risk scores (PRS) as part of the research programme’s aim to find new ways to prevent, detect and treat common diseases such as dementia, diabetes, heart disease, stroke, and cancer.
NHS pilots genetic testing to predict risk of heart disease
17 Jan 2022
An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.
Genomics plc announces extension of drug discovery collaboration with Vertex
3 Nov 2021
Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery
Genomics plc announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches
10 Oct 2022
Genomics plc have today announced a partnership with Our Future Health to generate polygenic risk scores (PRS) as part of the research programme’s aim to find new ways to prevent, detect and treat common diseases such as dementia, diabetes, heart disease, stroke, and cancer.
NHS pilots genetic testing to predict risk of heart disease
17 Jan 2022
An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.
Genomics plc announces extension of drug discovery collaboration with Vertex
3 Nov 2021
Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery
Genomics plc announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches
10 Oct 2022
Genomics plc have today announced a partnership with Our Future Health to generate polygenic risk scores (PRS) as part of the research programme’s aim to find new ways to prevent, detect and treat common diseases such as dementia, diabetes, heart disease, stroke, and cancer.
NHS pilots genetic testing to predict risk of heart disease
17 Jan 2022
An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.
Genomics plc announces extension of drug discovery collaboration with Vertex
3 Nov 2021
Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery
Genomics plc announces genetic risk scoring partnership with Our Future Health to test new personalised disease prevention approaches
10 Oct 2022
Genomics plc have today announced a partnership with Our Future Health to generate polygenic risk scores (PRS) as part of the research programme’s aim to find new ways to prevent, detect and treat common diseases such as dementia, diabetes, heart disease, stroke, and cancer.
NHS pilots genetic testing to predict risk of heart disease
17 Jan 2022
An article in The Guardian by Hannah Devlin on our HEART study looking at polygenic risk scores for the prevention of common diseases like cardiovascular disease.
Genomics plc announces extension of drug discovery collaboration with Vertex
3 Nov 2021
Companies confirm a two-year extension of their collaboration using genomics and machine learning to identify novel targets for innovative medicines and accelerate drug discovery